Schizophrenia: The cerebellum’s unexpected role

Illustrative image of the connectivity between the cerebellum and the VTA.
Image Credit: © Thomas Bolton

Scientific Frontline: "At a Glance" Summary

• Main Discovery: The cerebellum acts as a critical regulator of the brain's reward system, directly influencing the severity of "negative" schizophrenia symptoms such as apathy, loss of motivation, and social withdrawal.
• Specific Detail/Mechanism: Functional analysis reveals that the cerebellum modulates the dopamine-producing ventral tegmental area (VTA); stronger cerebellar regulation correlates with reduced negative symptoms, while weaker regulation is linked to increased symptom severity.
• Key Statistic or Data: The study established these findings by monitoring 146 patients over a period of 3 to 9 months, utilizing an independent validation cohort to confirm the functional connectivity between the cerebellum and the VTA.
• Context or Comparison: Unlike the VTA, which is located deep within the brain and is difficult to target, the cerebellum is situated superficially at the back of the skull, making it accessible for non-invasive interventions.
• Significance/Future Application: This mechanism identifies the cerebellum as a viable target for Transcranial Magnetic Stimulation (TMS); a randomized controlled trial is currently underway to test this therapeutic approach, with results expected in 2028.
• Additional Critical Detail: This research challenges the traditional view of the cerebellum as solely a motor control center, highlighting its pivotal role in emotional and cognitive processing relevant to psychiatric disorders.

Even brief lapses in attention can weaken memory

Photo Credit: RDNE Stock project

Scientific Frontline: "At a Glance" Summary

• Main Discovery: Brief lapses in attention (mind-wandering) during learning create measurable "cracks" in memory, making encountered information significantly less likely to be recognized later.
• Methodology: Researchers utilized "experience sampling," periodically pausing participants as they viewed complex scenes to record their immediate thoughts, and later tested retention via image recognition and drawing tasks.
• Key Correlation: In the drawing experiments, the depth of a mind-wandering episode directly correlated with the loss of specific visual details, providing visible evidence of the "cost" of distraction.
• Data Nuance: While intrinsically "memorable" images boosted simple recognition regardless of focus, performance on demanding tasks (like drawing from memory) only benefited from image memorability when participants remained attentive.
• Mechanism of Thought: A companion study revealed that the quality of task-related thought is critical; "unguided" or unstructured thinking predicted poorer memory, whereas "inner speech" and clear self-awareness significantly enhanced retention.
• Significance: The findings demonstrate that effective memory encoding depends not merely on staying "on task," but on the specific structural organization and quality of moment-to-moment conscious experience.

International research breakthrough for remote Alzheimer’s testing

Photo Credit: Courtesy of University of Exeter

A groundbreaking international study has demonstrated that Alzheimer’s disease biomarkers can be accurately detected using simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior processing. 

The research, led by US institute Banner Health working with the University of Exeter Medical School and supported by the National Institute for Health and Care Research (NIHR), published today in Nature Medicine. It represents the first large-scale validation of this accessible testing approach that removes geographic barriers and opens brain disease research to global populations without requiring specialized healthcare infrastructure. 

The DROP-AD project, conducted across seven European medical centers including the University of Gothenburg and University of Exeter, successfully tested 337 participants and proved that finger-prick blood collection can accurately measure key markers of Alzheimer’s pathology and brain damage. This breakthrough enables worldwide research participation by eliminating the logistical constraints that have historically limited biomarker studies to well-resourced medical facilities. 

What Is: Psychedelic Renaissance

The current "Psychedelic Renaissance" is not a new discovery but a recovery of lost knowledge.
Image Credit: Scientific Frontline

The Fourth Wave of Psychiatry

The field of psychiatry is currently undergoing its most significant paradigm shift since the introduction of the first psychopharmaceuticals in the mid-20th century. For decades, the standard of care for mental health disorders has been dominated by the monoamine hypothesis—the idea that regulating neurotransmitters like serotonin, dopamine, and norepinephrine through daily maintenance medication can rectify chemical imbalances. However, a growing body of evidence, accumulated largely over the last two decades and culminating in the pivotal events of 2024 and 2025, suggests that this model is incomplete. We are witnessing the rise of a "fourth wave" of psychiatry, characterized by the use of psychedelics: compounds that do not merely suppress symptoms but appear to catalyze profound, rapid, and durable healing through mechanisms of neuroplasticity and network reorganization.

This report serves as an exhaustive analysis of the current state of psychedelic medicine as of late 2025. It moves beyond the simplistic "shroom boom" narratives to dissect the complex neurobiology, the rigorous clinical trials, and the volatile regulatory landscape that defines this sector. The subject matter encompasses "classic" psychedelics like psilocybin and lysergic acid diethylamide (LSD), which primarily target the serotonin 2A receptor, as well as "atypical" psychedelics or entactogens like 3,4-methylenedioxymethamphetamine (MDMA).

Psychiatry: In-Depth Description

Scientific Frontline / stock image

Psychiatry is the branch of medicine exclusively dedicated to the diagnosis, treatment, and prevention of mental, emotional, and behavioral disorders.

Unlike psychology, which is the study of the mind and behavior, psychiatry is a medical discipline. Psychiatrists are qualified medical doctors (MD or DO) who specialize in the complex intersection of physical and mental health. The primary goal of the field is to alleviate suffering and improve well-being by managing conditions ranging from transient emotional crises to chronic, life-altering mental illnesses through a combination of pharmacological, psychotherapeutic, and psychosocial interventions.

Brain discovery opens door to earlier detection of metabolic syndrome in women

Image Credit: Scientific Frontline / stock image

McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life. 

A new study found that variations in the brain’s insulin receptor network affect how women respond to early-life adversity. This effect has a lesser impact in men, suggesting there is a sex-specific process at play. 

The findings, published in Communications Biology (Nature Portfolio), point to the brain’s insulin receptor network as a promising avenue for earlier detection and future prevention strategies for metabolic syndrome, a major driver of cardiovascular disease that affects about one in five Canadian adults. 

“We know that women who face childhood adversity are at higher risk for metabolic disease, and this study helps identify who is most susceptible,” said senior author Dr. Patricia Pelufo Silveira, professor of psychiatry at McGill and researcher at the Douglas Research Centre. 

What Is: Dementia

Illustration Credit: Scientific Frontline

The End of the Passive Era

The year 2025 marks a definitive inflection point in the history of neuroscience and geriatric medicine. For decades, the field of dementia care was characterized by a certain fatalism—a paradigm of "diagnose and manage" where the clinician’s role was largely to document decline and support the family. That era has officially closed. We have entered the age of precision intervention, defined by the ability to detect neurodegenerative pathology in blood plasma decades before symptoms arise, the availability of disease-modifying immunotherapies that clear toxic proteins from the brain, and a nuanced biological understanding that has shattered the monolithic concept of "senility" into a spectrum of distinct, treatable molecular events.

Our Scientific Frontline report provides an exhaustive analysis of the dementia landscape as it stands in late 2025. It synthesizes data from the latest clinical trials, including the landmark approval of subcutaneous maintenance dosing for anti-amyloid therapies, and examines the emerging economic reality where the global cost of dementia is projected to triple by mid-century. We explore the biological underpinnings of conditions ranging from classic Alzheimer’s Disease to the newly characterized Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), and we evaluate the transformative potential of 14 modifiable risk factors that could prevent nearly half of all cases.

Coffee linked to slower biological ageing among those with severe mental illness – up to a limit

Photo Credit: Julia Florczak

New research from King’s College London finds that coffee consumption within the NHS recommended limit is linked to longer telomere lengths – a marker of biological ageing – among people with bipolar disorder and schizophrenia. The effect is comparable to roughly five years younger biological age. 

Telomeres are structures that protect DNA. As people get older, their telomeres shorten as part of the natural human ageing process. This process has been shown to be accelerated among people with severe mental illness, such as bipolar disorder and schizophrenia, who have an average life expectancy 15 years shorter than the general population. 

Previous research shows that coffee has health benefits. It may reduce oxidative stress in the general population, helping slow biological ageing processes like telomere shortening. The new study, published in BMJ Mental Health, explores whether coffee consumption could slow this ageing process among those with severe mental illness. 

What Is: Narcissism

Image Credit: Scientific Frontline / AI generated

The term "narcissism" is one of the most frequently deployed yet widely misunderstood concepts in the modern psychological lexicon. Rooted in the Greek myth of Narcissus—the youth who fell in love with his own reflection—its popular use is often pejorative, synonymous with simple vanity or selfishness. In clinical and research contexts, however, the construct is far more complex. Narcissism is not a binary attribute but a self-centered personality style that exists on a continuum, ranging from normal and adaptive traits at one end to a severe, pathological personality disorder at the other. 

Lesser-known eating disorder just as severe as anorexia and bulimia

Photo Credit: Sehajpal Singh

A diagnosis often viewed as less serious than anorexia and bulimia – and the most common eating disorder worldwide – can cause just as much harm, a new study has found. 

Other Specified Feeding or Eating Disorder (OSFED) is diagnosed when a person’s symptoms don’t fit neatly into the classical categories but are still clinically significant. 

Researchers from McGill University and Douglas Research Centre compared clinical data from adults with OSFED to those with anorexia and bulimia. Across measures of depression, anxiety, well-being, and concerns about shape, weight and eating, they found people with OSFED were just as ill, and in some cases had more severe symptoms. 

Rare Brain Cell May Hold the Key to Preventing Schizophrenia Symptoms

A new study from the University of Copenhagen shows that a targeted intervention in a specific type of brain cell can change behavior in mice with symptoms resembling schizophrenia. The researchers hope that this knowledge may eventually pave the way for more targeted treatments for conditions such as schizophrenia.
Image Credit: Scientific Frontline / AI generated

A specific type of brain cell is abnormally active in mice exhibiting behavior reminiscent of schizophrenia, according to a new study from the University of Copenhagen. By dampening the activity of these cells, researchers were able to restore the animals’ behavior—an insight that may pave the way for a new preventive treatment.

Difficulty completing everyday tasks. Failing memory. Unusually poor concentration.

For many people living with schizophrenia, cognitive challenges are part of daily life. Alongside well-known symptoms such as hallucinations and delusions, these difficulties can make it hard to live the life they want. That is why researchers at the University of Copenhagen are working to find ways to prevent such symptoms - and they may now be one step closer.

In a new study, researchers discovered that a specific type of brain cell is abnormally active in mice displaying schizophrenia-like behavior. When the researchers reduced the activity of these cells, the mice’s behavior changed.

“Current treatments for cognitive symptoms in patients with diagnoses such as schizophrenia are inadequate. We need to understand more about what causes these cognitive symptoms that are derived from impairments during brain development. Our study may be the first step toward a new, targeted treatment that can prevent cognitive symptoms,” says Professor Konstantin Khodosevich from the Biotech Research and Innovation Center at the University of Copenhagen, and one of the researchers behind the study.

Large Genetic Study Links Cannabis Use to Psychiatric, Cognitive and Physical Health

The study uncovered new relationships between gene variants associated with cannabis use and psychiatric, cognitive and physical health.
Image Credit: Scientific Frontline / AI generated

University of California San Diego of Medicine researchers, in collaboration with the genetic testing company 23andMe, have identified regions of the human genome associated with cannabis use, uncovering new relationships with psychiatric, cognitive and physical health. The findings may inform the development of prevention and treatment strategies for cannabis use disorder. The study was published on October 13, 2025 in Molecular Psychiatry.

“Cannabis is widely used, but its long-term effects on health remain poorly characterized,” said Sandra Sanchez-Roige, Ph.D., associate professor of psychiatry at UC San Diego School of Medicine and senior author of the study. The researchers were also interested in the relationship between genetics and traits that contribute to the development of cannabis use disorder, which can interfere with a person’s daily life.

“While most people who try cannabis do not go on to develop cannabis use disorder, some studies estimate that nearly 30% will,” said Sanchez-Roige. “Understanding the genetics of early-stage behaviors may help clarify who is at greater risk, opening the door to prevention and intervention strategies.”

Very few regret a legal gender change in Sweden

“We saw that the vast majority of people who go through the process to legally change their gender do not reverse this decision," says Kristen Clark, the study’s lead author.
Photo Credit: Tobias Sterner/Bildbyrån

Fewer than one per cent of people who have changed their legal gender choose to revert to the gender they were assigned at birth. This has been shown in a new study from Uppsala University in which the researchers looked at how stable a gender change is over time.

A new study based on national data from Sweden provides strong evidence that legal gender change in people diagnosed with gender dysphoria is stable over time. Reversal occurs in less than one per cent of cases.

“We saw that the vast majority of people who go through the process to legally change their gender do not reverse this decision. Of the 2,467 people included in the study who had applied for and obtained a change in their legal gender, only 21 changed it back to the gender they had been assigned at birth. The probability that a legal gender change will remain stable after 10 years is therefore estimated at close to 98 per cent,” says Kristen Clark, postdoc at Department of Medical Sciences and the study’s lead author.

Childhood overeating can be a harbinger of later mental health struggles in girls, study finds

Photo Credit: Toa Heftiba

Girls who overeat regularly in preschool years are more likely to experience anxiety, impulsivity and hyperactivity in adolescence, according to a new study led by researchers at McGill University and the Douglas Research Centre.

The study followed more than 2,000 Quebec children using provincial data, tracking eating patterns reported by caregivers in early childhood and assessing mental-health symptoms when participants turned 15. The link between overeating and later difficulties was seen in girls, but not in boys.

What Is: Schizophrenia

 

Image Credit: Scientific Frontline

Beyond the Misconceptions

Schizophrenia is one of the most misunderstood mental health conditions. It is not, as commonly portrayed, a "split personality" (that is a separate, rare condition called dissociative identity disorder). Rather, schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. At its core, it is a disorder of cognition and reality testing, characterized by a "fracturing" of the mind's essential functions, leading to a disconnect from reality for the individual experiencing it.

Globally, schizophrenia affects approximately 24 million people, or 1 in 300 worldwide. It is a universal human illness that does not discriminate based on race, culture, or socioeconomic status.

Mystery solved: New study reveals how DNA repair genes play a major role in Huntington's disease

Dr. Xiangdong William Yang
Photo Credit: Courtesy of UCLA/Health

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and triggering downstream pathologies and motor impairment, shedding light on disease mechanisms and potential new ways to develop therapies. 

Huntington’s disease is one of the most common inherited neurodegenerative disorders that typically begins in adulthood and worsens over time. Patients begin to lose neurons in specific regions of the brain responsible for movement control, motor skill learning, language and cognitive function. Patients typically live 15 to 20 years after diagnosis with symptoms worsening over time. There is no known cure or therapy that alters the course of the disease.

The cause of Huntington's disease was discovered over three decades ago--a "genetic stutter" mutation involves repeats of three letters of the DNA, cytosine-adenine-guanine (CAG), in a gene called huntingtin. Healthy individuals usually have 35 or fewer CAG repeats, but people inherited with mutation of 40 or more repeats will develop the disease. The more CAG repeats a person inherits, the earlier the disease onset occurs. However, how the mutation causes the disease remains poorly understood. 

Study reveals reasons for misdiagnosis of frontotemporal dementia

Researchers have discovered patterns in the misdiagnosis of frontotemporal dementia
Photo Credit: Anna Shvets

University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease, in a study aimed at identifying factors that contribute to misdiagnosis of this notoriously difficult to diagnose disorder.

Psychiatrist Dr Joshua Flavell, working with cognitive neurologist Professor Peter Nestor at the Mater Hospital Memory and Cognitive Disorders clinic and UQ’s Queensland Brain Institute, analyzed data from 100 patients suspected of having frontotemporal dementia who had been referred by specialist physicians like neurologists, psychiatrists or geriatricians.

“Of the 100 patients, 34 were true-positive, and 66 were false-positive for frontotemporal dementia,” Dr Flavell said.

“We found that misinterpretation of brain scans, particularly nuclear imaging, led to 32 patients being incorrectly diagnosed.

What drives mood swings in bipolar disorder? Study points to a second brain clock

Image Credit: Scientific Frontline

A brain rhythm working in tandem with the body’s natural sleep-wake cycle may explain why bipolar patients alternate between mania and depression, according to new research.

The McGill University-led study published in Science Advances marks a breakthrough in understanding what drives shifts between the two states, something that, according to lead author Kai-Florian Storch, is considered the “holy grail” of bipolar-disorder research.

“Our model offers the first universal mechanism for mood switching or cycling, which operates analogously to the sun and the moon driving spring tides at specific, recurring times,” said Storch, an Associate Professor in McGill’s Department of Psychiatry and a researcher at the Douglas Research Centre.

The findings suggest that regularly occurring mood switches in bipolar disorder patients are controlled by two “clocks”: the biological 24-hour clock, and a second clock that is driven by dopamine-producing neurons that typically influence alertness. A manic or depressed state may arise depending on how these two clocks, which run at different speeds, align at a given time.

Researchers detect that people with schizophrenia have an altered ability to visually perceive contrast

UB researchers Cristina de la Malla and Daniel Linares.
Photo Credit: Courtesy of University of Barcelona

According to a review of more than 600 studies, these patients would have difficulty in detecting differences in light intensity between adjacent areas, without which they cannot adequately see their surroundings and objects.

The article, published in the journal Schizophrenia Bulletin, is signed by researchers Daniel Linares and Cristina de la Malla, together with master’s student Aster Joostens, from the Vision and Control of Action Group of the Faculty of Psychology and the UB Institute of Neurosciences (UBneuro).

A key indicator of visual function

The symptoms of schizophrenia are characterized by alterations in thinking and behavior, such as loss of contact with reality, delusions or hallucinations, but there are also abnormalities in the perception of visual stimuli, such as deficits in the perception of color or contrast. Understanding these abnormalities may provide clues as to how information processing disturbances contribute to the characteristic symptoms of schizophrenia. “Contrast perception is one of the most fundamental abilities of vision, as without it, we cannot adequately perceive the environment and the objects in it, which can compromise everyday tasks such as moving through space, recognizing faces or reading”, explains the research team, part of the Department of Cognition, ​​​​​​​Development and Educational Psychology.

Drawing a Line from the Gut Microbiome to Inflammation and Depression

Morganella morganii bacteria on a plate.
Photo Credit: Ajay Kumar Chaurasiya
(CC BY-SA 4.0)

It’s become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial species influence the development of disease and how they do so, however, is only just starting to be unraveled.

For instance, some studies have found compelling links between one species of gut bacteria, Morganella morganii, and major depressive disorder. But until now no one could tell whether this bacterium somehow helps drive the disorder, the disorder alters the microbiome, or something else is at play.

Harvard Medical School researchers have now pinpointed a biologic mechanism that strengthens the evidence that M. morganii influences brain health and provides a plausible explanation for how it does so.

The findings, published in the Journal of the American Chemical Society, implicate an inflammation-stimulating molecule and offer a new target that could be useful for diagnosing or treating certain cases of the disorder. They also provide a roadmap for probing how other members of the gut microbiome influence human health and behavior.

“There is a story out there linking the gut microbiome with depression, and this study takes it one step further, toward a real understanding of the molecular mechanisms behind the link,” said senior author Jon Clardy, the Christopher T. Walsh, PhD Professor of Biological Chemistry and Molecular Pharmacology in the Blavatnik Institute at HMS.